IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 42 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 18,000 | $207,000 | 0.09% |
| Hartree Partners, LP | 642,500 | $51,400,000 | 0.04% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,487,000 | 0.04% |
| TEGEAN CAPITAL MANAGEMENT, LLC | 45,710 | $2,002 | 0.01% |
| MARSHALL WACE, LLP | 224,997 | $2,231,000 | 0.01% |
| Ayrton Capital LLC | 28,393 | $2,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,499 | $134,000 | 0.00% |
| EHP Funds Inc. | 109,569 | $11,000 | 0.00% |
| COWEN AND COMPANY, LLC | 250,974 | $21,000 | 0.00% |
| Alpine Global Management, LLC | 61,625 | $5,000 | 0.00% |